Cochrane Abstracts
Angiogenesis-inhibitors for metastatic thyroid cancer: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Angiogenesis-inhibitors for Metastatic Thyroid Cancer: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436841/all/Angiogenesis_inhibitors_for_metastatic_thyroid_cancer:_Cochrane_systematic_review.
Angiogenesis-inhibitors for metastatic thyroid cancer: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436841/all/Angiogenesis_inhibitors_for_metastatic_thyroid_cancer:_Cochrane_systematic_review. Accessed March 15, 2025.
Angiogenesis-inhibitors for metastatic thyroid cancer: Cochrane systematic review. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436841/all/Angiogenesis_inhibitors_for_metastatic_thyroid_cancer:_Cochrane_systematic_review
Angiogenesis-inhibitors for Metastatic Thyroid Cancer: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436841/all/Angiogenesis_inhibitors_for_metastatic_thyroid_cancer:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Angiogenesis-inhibitors for metastatic thyroid cancer: Cochrane systematic review
ID - 436841
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436841/all/Angiogenesis_inhibitors_for_metastatic_thyroid_cancer:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
